Rivera, F., Romero, C., Jimenez-Fonseca, P., Izquierdo-Manuel, M., Salud, A., Martínez, E., . . . López, C. (2019). Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial. Cancer Chemother Pharmacol.
Citação norma ChicagoRivera, Fernando, et al. "Phase II Study to Evaluate the Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin in First-line Treatment of HER2-positive Advanced Gastric Cancer: HERXO Trial." Cancer Chemother Pharmacol 2019.
Citação norma MLARivera, Fernando, et al. "Phase II Study to Evaluate the Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin in First-line Treatment of HER2-positive Advanced Gastric Cancer: HERXO Trial." Cancer Chemother Pharmacol 2019.